I've realised that a letter to the Ethics Co-ordinator is probably a bit premature. I've sent the following letter to Dr Li, the study lead.
Dear Dr Li,
I understand that you are the lead investigator on a study looking at the effect of hormones on CFS. Can you please confirm that this poster advertising for participants was used for recruitment and was approved by you and Professor Lloyd?
The term 'ovary-reacting' would be laughably puerile coming from a 16-year old on Reddit. It is a great deal more concerning than that coming from researchers whose findings may impact on the treatment of people with ME/CFS and who are using scarce research funds.
I presume you are aware that people with ME/CFS have to deal not only with a life-changing illness, one that results in a significant proportion of sufferers, men and women, being house-bound or even bed-bound for decades, but also with a perception, unsupported by evidence, that the illness is 'all in the mind' and a product of an over-reaction to the difficulties of normal life? In that context, the question 'Are women with CFS ovary-reacting?' is deeply concerning. If that phrase is thought suitable to be used in a recruitment advertisement it raises questions about the biases of the researchers.
I am interested to know what criteria has been used to select the participants. The criteria on the poster ('Experiencing significant and chronic fatigue') could include participants with a very wide range of causes of their fatigue. The Participant Information Statement is rather better, requiring a diagnosis of CFS and suggesting there will be further screening questions. However it still does not specify what formal criteria schedule is being used. Patients deserve to know what criteria will be used prior to committing their time to a study.
ME/CFS is much more than just fatigue. Indeed, someone who is able to reduce their activity levels sufficiently may not even rate fatigue as amongst their most concerning symptoms. While some people with ME/CFS may have problems with mood, many do not. The selection of items to measure (fatigue symptoms, mood and thought processes) is therefore curious. Why were no objective measures chosen such as steps walked, neurocognitive tests, temperature upon waking or morning heart rate increase on standing?
You don't appear to have any healthy controls or controls with another chronic illness. Is this because you feel that you have a deep knowledge of the levels and fluctuations in fatigue, mood and thought processes that healthy women and women with other debilitating illnesses with similar activity levels experience during their menstrual cycle, as measured with the same instruments that you are using? It is rather surprising that this biomedical study is being run by 3 people from a School of Psychology. Would it not have been useful to have a least one expert in female hormones on the team?
A study of how ME/CFS symptoms vary with changes in female hormones could lead to some useful insights, but I am concerned that a lack of a good understanding of the illness has limited the utility of your work and may even result in recommendations that harm rather than help the progress towards a better understanding of the illness.
I will post this letter and your reply on the international forum Science for ME. You are very welcome to join us there to discuss things further if you would like to.
Kind regards,